3 Analysts Make Bullish Calls on Tilray Stock

Analysts believe Tilray is positioned well for growth in the adult-use market

Aug 13, 2018 at 9:38 AM
facebook twitter linkedin

Tilray Inc (NASDAQ:TLRY) has had a good month, suffering only one negative session so far in August. In the last week alone, the shares added 6.92%, though they had trouble taking out the $26 mark, which had acted as a ceiling in recent weeks. Today, TLRY stock has burst through this level, last seen trading up 4.6% at $27, thanks to upbeat analyst attention.

Brokerage firm Northland Capital initiated coverage with an "outperform" rating and price target of $35. In addition, Eight Capital and Cowen initiated coverage on the medical marijuana stock with "buy" ratings, along with respective price targets of $32 and $34. The analysts at Eight Capital and Cowen said Tilray is in strong position to be a leader in the adult-use market, and Eight Capital suggested the company may be uniquely able to get investments from pharmaceutical firms.

Cowen's $34 price target is especially notable since that's double TLRY's IPO price, and the equity actually topped out at $34.10 back on July 23 in its third day of trading. The company is set to report earnings for the first time since going public later this month, with the release scheduled for after the close on Tuesday, Aug. 28.


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Schaeffer's Daily Bulletin Offer


Special Offers from Schaeffer's Trading Partners